{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:20:31Z","timestamp":1769635231891,"version":"3.49.0"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,8,1]]},"abstract":"<jats:p>Excessive or thick pulmonary secretions are a common clinical challenge in the neonatal population. Mucus accumulation can cause many life-threatening complications, including plugging of the endotracheal tube and increasing the risk of pulmonary infections. We report 3 premature neonates who had critical pulmonary collapse secondary to mucous plugging. Different conventional methods to liquefy mucus and facilitate removal of secretions were exhausted to no avail. The rescue use of DNase was effective in reestablishing airway patency. Thus, this drug could be a valuable tool in treating atelectasis and mucus-plugging in mechanically ventilated, premature neonates.<\/jats:p>","DOI":"10.1542\/peds.108.2.468","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"468-470","source":"Crossref","is-referenced-by-count":38,"title":["Rescue Use of DNase in Critical Lung Atelectasis and Mucus Retention in Premature Neonates"],"prefix":"10.1542","volume":"108","author":[{"given":"Nahed O. El","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia R.","family":"Chess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne W. A.","family":"Huysman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J. F. M.","family":"Merkus","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan C.","family":"de Jongste","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2001,8,1]]},"reference":[{"key":"2021121003560729300_B1"},{"key":"2021121003560729300_B2"},{"key":"2021121003560729300_B3","first-page":"909","article-title":"Studies on pulmonary secretions: the nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy.","volume":"9","author":"Potter","year":"1969","journal-title":"Am Rev Respir Dis"},{"key":"2021121003560729300_B4","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase reduces the viscosity of cystic fibrosis sputum.","volume":"87","author":"Shak","year":"1990","journal-title":"Proc Natl Acad Sci U\u2009S\u2009A"},{"key":"2021121003560729300_B5","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jama.1992.03480140073036","article-title":"Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis.","volume":"267","author":"Aitken","year":"1992","journal-title":"JAMA"},{"key":"2021121003560729300_B6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(95)92436-1","article-title":"Human recombinant DNase for mucus plugging in status asthmaticus.","volume":"346","author":"Greally","year":"1995","journal-title":"Lancet"},{"key":"2021121003560729300_B7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ppul.1950180414","article-title":"Resolution of chronic atelectasis in a child with asthma after aerosolized recombinant human DNase.","volume":"18","author":"Gershan","year":"1994","journal-title":"Pediatr Pulmonol"},{"key":"2021121003560729300_B8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/thx.50.12.1319","article-title":"Recombinant human DNase in management of lobar atelectasis due to retained secretions.","volume":"50","author":"Touleimat","year":"1995","journal-title":"Thorax"},{"key":"2021121003560729300_B9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/BF01708100","article-title":"Resolution of recurrent atelectasis in spinal cord injury patients with administration of recombinant human DNase.","volume":"22","author":"Voelker","year":"1996","journal-title":"Intensive Care Med"},{"key":"2021121003560729300_B10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1099-0496(199901)27:1<59::AID-PPUL11>3.0.CO;2-D","article-title":"DNase treatment in primary ciliary dyskinesia\u2014assessment by nocturnal pulse oximetry.","volume":"27","author":"Ten Berge","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"2021121003560729300_B11","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00003246-200002000-00045","article-title":"Resolution of mucusplugging and atelectasis after intracheal RhDNase therapy in a mechanically ventilated child with refractory status asthmaticus.","volume":"28","author":"Durward","year":"2000","journal-title":"Crit Care Med"},{"key":"2021121003560729300_B12","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.","volume":"87","author":"Shak","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021121003560729300_B13","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2165\/00003495-199448060-00006","article-title":"Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis.","volume":"48","author":"Bryson","year":"1994","journal-title":"Drugs"},{"key":"2021121003560729300_B14","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/thx.51.7.750","article-title":"The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.","volume":"51","author":"Zach","year":"1996","journal-title":"Thorax"},{"key":"2021121003560729300_B15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human Dnase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis.","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"2021121003560729300_B16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1099-0496(199808)26:2<147::AID-PPUL14>3.0.CO;2-1","article-title":"Safety of endotracheal rhDNase for treatment of pulmonary atelectasis in mechanically ventilated children.","volume":"26","author":"Boeuf","year":"1998","journal-title":"Pediatr Pulmonol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/2\/468\/1164873\/e1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/2\/468\/1164873\/e1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T11:29:14Z","timestamp":1639135754000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/108\/2\/468\/63769\/Rescue-Use-of-DNase-in-Critical-Lung-Atelectasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,1]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,8,1]]},"published-print":{"date-parts":[[2001,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.108.2.468","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8,1]]}}}